The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Trial in progress: Phase II study of niraparib and dostarlimab for the treatment of germline or somatic homologous recombination repair mutated metastatic pancreatic cancer.
 
Robert R. McWilliams
Stock and Other Ownership Interests - Zentalis
Consulting or Advisory Role - Zentalis
Research Funding - Bristol-Myers Squibb (Inst); GlaxoSmithKline/Tesaro (Inst); Merck (Inst); Newlink Genetics (Inst)
 
Pashtoon Murtaza Kasi
Consulting or Advisory Role - Bayer; Boston Healthcare Associates; Daiichi Sankyo/Astra Zeneca; Delcath Systems; Eisai; Exact Sciences; Foundation Medicine; Inflecton Point Biomedical Advisors; Ipsen (Inst); Lilly; MSD Oncology; Natera; QED Therapeutics; Seagen; SERVIER; Taiho Oncology; Taiho Pharmaceutical (Inst); Tempus
Research Funding - Advanced Accelerator Applications (Inst); Boston Scientific (Inst); Tersera (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Nathan R. Foster
No Relationships to Disclose
 
Mojun Zhu
No Relationships to Disclose
 
Ryan Michael Carr
No Relationships to Disclose
 
Wen Wee Ma
Research Funding - Actuate Therapeutics (Inst); Athenex (Inst); BioMed Valley Discoveries (Inst); Bristol-Myers Squibb (Inst); Cardiff Oncology (Inst); Elucida Oncology (Inst); Genentech (Inst); Ipsen (Inst); Jacobio (Inst); Sun Pharma (Inst)
 
Mindy L. Hartgers
No Relationships to Disclose
 
Kayla M. Jones
No Relationships to Disclose
 
Jacqueline M. Bartusiewicz
No Relationships to Disclose
 
Haidong Dong
No Relationships to Disclose
 
Svetomir Markovic
Stock and Other Ownership Interests - Sorrento Therapeutics
Consulting or Advisory Role - Sorrento Therapeutics
Research Funding - Bristol-Myers Squibb; Nektar; Sorrento Therapeutics
Patents, Royalties, Other Intellectual Property - Nanoparticles (patents); Nanoparticles - immunoconjugates
 
Steven R Alberts
No Relationships to Disclose
 
Daniel H. Ahn
Stock and Other Ownership Interests - Natera
Consulting or Advisory Role - Advanced Accelerator Applications; Daiichi Sankyo/Astra Zeneca; Eisai; Exelixis; Genentech/Roche; Novartis
Research Funding - AstraZeneca; Bayer
 
Hani M. Babiker
Consulting or Advisory Role - Celgene; Endocyte; Idera; Myovant Sciences; Novocure
Speakers' Bureau - Guardant Health
 
Tanios S. Bekaii-Saab
Consulting or Advisory Role - Abbvie; Amgen (Inst); Arcus Biosciences (Inst); AstraZeneca; Bayer (Inst); BeiGene; Boehringer Ingelheim; Celularity; Daiichi Sankyo/UCB Japan; Deciphera; Eisai; Eisai; Exact Sciences; Foundation Medicine; Foundation Medicine; Illumina; Immuneering; Incyte (Inst); Ipsen (Inst); Janssen; Kanaph Therapeutics; Lilly (Inst); Natera; Pfizer (Inst); Roche/Genentech (Inst); Seagen (Inst); SOBI; Stemline Therapeutics; Treos Bio
Patents, Royalties, Other Intellectual Property - Patent WO/2018/183488; Patent WO/2019/055687
Other Relationship - 1Globe Health Institute; AstraZeneca; Exelixis; FibroGen; Imugene; Lilly; Merck (Inst); Pancreatic Cancer Action Network; Replimune; Sun Biopharma; Suzhou Kintor Pharmaceuticals; UpToDate; Xilis
 
Fergus Couch
Honoraria - Ambry Genetics/Konica Minolta; Natera; US Oncology Network
Consulting or Advisory Role - AstraZeneca
Speakers' Bureau - Ambry Genetics; Qiagen
Research Funding - GRAIL
Travel, Accommodations, Expenses - GRAIL
Other Relationship - Ambry Genetics